Home / Companies / Novadoz Pharmaceuticals Llc / Trends
Novadoz Pharmaceuticals Llc H-1B trends
Quarterly LCA aggregate trend points for Novadoz Pharmaceuticals Llc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Novadoz Pharmaceuticals Llc span 2023 Q4 to 2025 Q3, peaking at 2 filings in 2025 Q3.
The most recent reported period (2025 Q3) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 1 | 1 | 1 | $175,000 | $169,042 | 1 | 100.0% |
| 2025 Q3 | 2 | 1 | 2 | $63,596 | $63,596 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Novadoz Pharmaceuticals Llc changed over time?
- H-1B LCA filings for Novadoz Pharmaceuticals Llc span 2023 Q4 to 2025 Q3, peaking at 2 filings in 2025 Q3. The most recent reported period (2025 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=novadoz+pharmaceuticals+llc&metric=lca_countJSON